Health & Wellbeing

Pfizer and BioNTech have announced their large Phase 3 COVID-19 vaccine trial is complete. The trial has reportedly met all its primary endpoints and the vaccine is claimed to be 95 percent effective.

A new study has shone a light on the health benefits of short bursts of vigorous exercise, finding that they can produce “striking” effects on the metabolites circulating through the body and lead to improvements in a wide range of bodily functions.

A new observational study, analyzing data from nearly half a million UK subjects, suggests improving sleep behavior is an important intervention for both clinicians and patients looking to reduce risk of heart failure.

A week after Pfizer reported its COVID-19 vaccine is effective, biotechnology company Moderna has revealed similar results from its own vaccine candidate. But experts suggest the challenge ahead will be overcoming the logistical hurdles of mass vaccinations.

A proof-of-concept study proposes a novel, cheap and surprisingly simple way to rapidly reduce blood alcohol levels. The research suggests a low-tech device aiding safe hyperventilation can more than triple the rate of alcohol elimination from the body.

Days after Pfizer revealed vaccine trial data, Russian authorities have announced their vaccine candidate is also demonstrating promising results. Experts call the Russian data encouraging, but caution the results are premature and based on low numbers.

A new flow visualization study from the National Institute of Standards and Technology (NIST) starkly demonstrates why face masks with exhalation valves are not effective for slowing the spread of COVID-19.

A new analysis of US patient data has found nearly one in five people are diagnosed with a psychiatric illness within three months of a positive COVID-19 test. The study suggests recovered patients are twice as likely to suffer from anxiety or depression.

Preliminary results from a trial investigating whether time-restricted eating influences weight loss suggest limiting your caloric intake may be more important than what time you eat. The research, not yet published or peer-reviewed, will be presented at the upcoming American Heart Association’s virtual Scientific Sessions meeting.

The FDA has just approved the first coronavirus-specific antibody treatment for moderate cases of COVID-19. The focused Emergency Use Authorization (EUA) is aimed at newly diagnosed infections at the highest risk of progressing to severe disease.

The first data from Pfizer's Phase 3 COVID-19 vaccine trial suggests the experimental mRNA candidate is more than 90 percent effective in preventing symptomatic disease. Experts say these results are encouraging, but it is still early days.

To overcome the stereotypical emotionless "Botox face," physicians have been working on novel ways to administer the paralytic toxin that generate a more natural outcome. A new study reveals a novel Botox microdose therapy is both safe and effective